AbbVie Inc (ABBV)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	33,002,000	33,224,000	28,852,000	26,488,000	28,463,000	30,364,000	29,100,000	26,509,000	27,928,000	28,957,000	25,999,000	26,569,000	24,173,000	23,009,000	21,256,000	51,758,000	49,519,000	20,166,000	15,100,000	14,413,000
Total current liabilities	US$ in thousands	37,841,000	34,773,000	32,239,000	27,590,000	29,538,000	32,712,000	34,473,000	32,521,000	35,194,000	28,533,000	28,684,000	31,951,000	28,661,000	24,181,000	24,646,000	16,471,000	15,585,000	17,493,000	16,941,000	13,904,000
Current ratio		0.87	0.96	0.89	0.96	0.96	0.93	0.84	0.82	0.79	1.01	0.91	0.83	0.84	0.95	0.86	3.14	3.18	1.15	0.89	1.04

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $33,002,000K ÷ $37,841,000K
= 0.87

AbbVie Inc's current ratio provides insight into the company's short-term liquidity and ability to cover its current liabilities with its current assets. The current ratio has fluctuated over the past eight quarters, ranging from a low of 0.82 in Q1 2022 to a high of 0.96 in Q3 2023.

A current ratio below 1 indicates that the company may have difficulty meeting its short-term obligations. AbbVie's current ratio has mostly hovered around the 0.9 range, suggesting a slight shortfall in current assets compared to current liabilities.

While the current ratio is important for assessing short-term liquidity, it should be considered in conjunction with other financial metrics to provide a comprehensive view of AbbVie's financial health. It may be useful for investors and stakeholders to monitor any trends or deviations in the current ratio over time to evaluate changes in the company's liquidity position.